Владислав Матреницький та Дар’я Шапошник-Домінська прийняли учать у великій зустрічи...
Найкращі результати досягаються у поєднанні з психотерапією до, під час та після сесії. Сам досвід прийому — не просто хімія, а унікальний суб’єктивний стан, який потрібно правильно інтегрувати. Психоделічна медицина — це не лише ліки майбутнього, а новий підхід до зцілення, що поєднує науку, психотерапію та глибоку роботу з психікою. Вони відкривають нові горизонти у лікуванні депресії, ПТСР, залежностей та екзистенційної тривоги.
Ketamine psychotherapy session at our center
Psychopharmacology has barely advanced in recent decades: the number of FDA-approved drugs for the treatment of mental disorders has dropped from 13 in 1996 to just one in 2016.
Classic antidepressants act slowly, often do not provide complete remission, and have a number of serious side effects (weight gain, sexual dysfunction, heart problems, etc.).
In response to the impasse of traditional medicine, interest in psychedelic substances has rekindled—drugs that expand consciousness and can quickly affect the psyche.
After a period of active research in the 1950s–1970s (over 1,000 papers, 40,000 patients), all psychedelics were banned in the United States in the 1970s. The reasons were not only abuse, but also social upheaval caused by protests against the Vietnam War.
Since the early 2000s, the study of psychedelic substances has resumed, and over the past decade, their scientific research has become one of the most dynamic fields of medicine.
Today, over 400 clinical trials have been registered, and the FDA has granted breakthrough therapy status to psilocybin (depression) and MDMA (PTSD).
Psychedelics are not drugs in the traditional sense: they are not toxic, do not cause addiction, and do not have a pronounced withdrawal syndrome.
Their action is associated with the activation of serotonin receptors (5-HT2A), which affect emotions, mood, cognition, learning, inflammation, and brain plasticity.
Therefore, they were given a new name - psychoplastogens - drugs capable of restructuring pathological neural circuits even after a single dose .
Classic : psilocybin, LSD, DMT, mescaline.
MDMA (ecstasy): acts through serotonin and dopamine.
Кетамін: дисоціативний анестетик, антагоніст NMDA-рецепторів.
Other substances : ibogaine, salvinorin A — with unique mechanisms of action.
Psychedelics weaken the ego, opening up access to the subconscious. This allows:
to process psychological traumas more deeply,
change destructive thinking patterns,
find new meanings and resources for healing.
Many patients describe the experience as one of the most important events in their lives , opening the way to deep self-discovery.
A sense of unity, awe, timelessness, enlightenment—all of this contributes to lasting positive changes in behavior, emotions, and worldview.
Help in restoring psychological balance and resource.
Dealing with anxiety, physical symptoms, and fear of losing control
Modern methods of overcoming fears that prevent you from living.
Therapy for people with post-traumatic stress disorder.
Порушення здоров’я, яке виникає через соматизацію, тобто «втілення» негативних емоцій у тілі.
Психоонкологія — це психотерапевтична допомога пацієнтам, які хворіють на рак.
Владислав Матреницький та Дар’я Шапошник-Домінська прийняли учать у великій зустрічи...
Report by V. L. Matrenytsky at the International Scientific and Practical Conference “Psychedelic-Assisted Therapy in the Treatment of Post-Traumatic Conditions. International Experience and Prospects for Implementation in Ukraine”
Report by the director of the Expio Center, Vladyslav Matrenytskyi, “Integrative Ketamine-Assisted Psychotherapy: Six Years of Experience in Ukraine” at the First Ukrainian Symposium on Ketamine-Assisted Psychotherapy.
What is ketamine therapy and how it is used to treat mental disorders - in the material hromadske.
Media coverage of ketamine therapy:
Scientific articles about ketamine therapy:
The license of the State Medical Service of Ukraine for the use of ketamine in clinical practice was issued to the Expio LLC medical center by order No. 1065 dated July 11, 2024 (previously by order dated October 25, 2018 to the individual entrepreneur Matrenytskyi V.L.).
Refutation of tabloid publications about the illegal use of ketamine by the Expio Center
Based on the article "The Renaissance of Psychedelic Therapy and Its Significance for Ukraine"
V. L. Matrenytsky, Candidate of Medical Sciences
Medical Science, 2022, (3–4), 37–59. https://liksprava.com/index.php/journal/article/view/498/447
We are always open to communication. Contact us - we will answer all your questions and help you find the right solution.
Expio in Kyiv
Expio in Lviv
Ліцензія МОЗ України: наказ №1443 від 11.08.2023. Ліцензія ДержЛікСлужби України: наказ № 1065 від 11.07.2024
(з 2018 по 2024 р. наказ ДЛС від 25.10.2018 на ФОП Матреницький В.Л.)
© Expio 2025 All rights reserved. / Developed by Bereshkaweb